busulfan has been researched along with Hyperdactyly in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "In busulfan-treated embryos, diffuse cell death was evident in both ectoderm and mesoderm, peaking at E13." | 1.34 | Busulfan-induced central polydactyly, syndactyly and cleft hand or foot: a common mechanism of disruption leads to divergent phenotypes. ( Naruse, T; Oberg, KC; Ogino, T; Takagi, M; Takahara, M, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Naruse, T | 1 |
| Takahara, M | 1 |
| Takagi, M | 1 |
| Oberg, KC | 1 |
| Ogino, T | 1 |
1 other study available for busulfan and Hyperdactyly
| Article | Year |
|---|---|
Busulfan-induced central polydactyly, syndactyly and cleft hand or foot: a common mechanism of disruption leads to divergent phenotypes.
Topics: Abnormalities, Drug-Induced; Animals; Antineoplastic Agents, Alkylating; Busulfan; Disease Models, A | 2007 |